Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELRANATAMAB-BCMM: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

49.4%
Female
50.6%
Male

Age Information

The average age of patients reporting adverse events with ELRANATAMAB-BCMM is 69.5 years.

Geographic Distribution

The majority of adverse event reports for ELRANATAMAB-BCMM originate from JP.

Report Summary & Outcomes

570
Total Reports
570
As Primary/Secondary Suspect
120
Deaths Reported
168
Hospitalizations
23
Life-Threatening
1
Disabilities

Reporting Timeline

First adverse event report: 20211108. Most recent report: 20250922. View full timeline →

More About ELRANATAMAB-BCMM

ELRANATAMAB-BCMM Full Profile Reports by Year Drug Interactions